Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: Free Radic Biol Med. 2021 Feb 17;166:73–89. doi: 10.1016/j.freeradbiomed.2021.02.006

Figure 5.

Figure 5.

KYC Decreased HMGB1 Release in Lungs of Hyperoxic Pups. Representative immunoblots for HMGB1 and Actin in lung lysates from hyperoxic pups treated with PBS (left) or KYC (right). These immunoblots show that KYC treatment decreased HMGB1 release in lung lysates isolated from hyperoxic pups relative to differences in Actin, an internal loading control. The bar chart shows relative changes in the mean ± SD of HMGB1 band densities relative to the band densities of Actin in lung lysates from hyperoxic pups treated with PBS or KYC (■: Hyperoxia + PBS, n=10; ▲: Hyperoxia + KYC; n=11, * = p<0.05).